Antibody drug conjugates

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9415118
APP PUB NO 20140308201A1
SERIAL NO

14204023

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to anti-FGFR2 antibodies, antibody fragments, antibody drug conjugates, and their uses for the treatment of cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVARTIS AGLICHTSTRASSE 35 4056 BASEL SWITZERLAND

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Batt, David Bryant Wayland, US 10 74
Ettenberg, Seth Alexander Melrose, US 11 71
Haubst, Nicole Munich, DE 21 131
Hu, Tiancen Cambridge, US 20 328
Jenkins, David Carlisle, US 95 1953
Meyer, Matthew John Framingham, US 14 75
Petropoulos, Konstantin Munich, DE 6 35
Toksoz, Engin Munich, DE 8 37

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 16, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00